Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) EPS (Weighted Average and Diluted): 2020-2024

Historic EPS (Weighted Average and Diluted) for Praxis Precision Medicines (PRAX) over the last 5 years, with Dec 2024 value amounting to -$10.21.

  • Praxis Precision Medicines' EPS (Weighted Average and Diluted) fell 22.18% to -$3.36 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.96, marking a year-over-year decrease of 39.50%. This contributed to the annual value of -$10.21 for FY2024, which is 45.37% up from last year.
  • Praxis Precision Medicines' EPS (Weighted Average and Diluted) amounted to -$10.21 in FY2024, which was up 45.37% from -$18.69 recorded in FY2023.
  • In the past 5 years, Praxis Precision Medicines' EPS (Weighted Average and Diluted) ranged from a high of -$3.94 in FY2021 and a low of -$69.65 during FY2022.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$18.69 (2023), whereas its average is -$32.85.
  • As far as peak fluctuations go, Praxis Precision Medicines' EPS (Weighted Average and Diluted) slumped by 1,667.77% in 2022, and later soared by 73.17% in 2023.
  • Praxis Precision Medicines' EPS (Weighted Average and Diluted) (Yearly) stood at -$7.86 in 2020, then soared by 49.87% to -$3.94 in 2021, then crashed by 1,667.77% to -$69.65 in 2022, then spiked by 73.17% to -$18.69 in 2023, then soared by 45.37% to -$10.21 in 2024.